PAR-1, -4, and the mTOR Pathway Following Germinal Matrix Hemorrhage

Acta Neurochir Suppl. 2016:121:213-6. doi: 10.1007/978-3-319-18497-5_38.

Abstract

Germinal matrix hemorrhage (GMH) is the most common cause of neurological complications of prematurity and has lasting implications. PAR-1 and PAR-4 receptors are involved with upstream signaling pathways following brain hemorrhage in adult models of stroke, of which the mammalian target of rapamycin (mTOR) is a potential downstream mediator. Therefore, we hypothesized a role for PAR-1, -4/ mTOR signaling following GMH brain injury. Postnatal day 7 Sprague-Dawley rats were subjected to GMH through stereotactic infusion of collagenase into the right ganglionic eminence. Rodents were euthanized at 72 h (short term), or 4 weeks (long term). Short-term mTOR expression was evaluated by Western blot in the context of PAR-1 (SCH-79797) and PAR-4 (P4pal10) inhibition. Pups in the long-term group were administered the selective mTOR inhibitor (rapamycin) with neurobehavioral and brain pathological examinations performed at 4 weeks. Pharmacological PAR-1, -4 antagonism normalized the increased mTOR expression following GMH. Early inhibition of mTOR by rapamycin improved long-term outcomes in rats. Mammalian-TOR signaling plays an important role in brain injury following neonatal GMH, possibly involving upstream PAR-1, -4 mechanisms.

Keywords: Germinal matrix hemorrhage; Hydrocephalus; Neonatal rats; Neurological dysfunction; Stroke, experimental.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Animals, Newborn
  • Behavior, Animal / drug effects
  • Blotting, Western
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Immunosuppressive Agents / pharmacology
  • Intracranial Hemorrhages / metabolism*
  • Intracranial Hemorrhages / pathology
  • Intracranial Hemorrhages / physiopathology
  • Oligopeptides / pharmacology*
  • Platelet Aggregation Inhibitors*
  • Pyrroles / pharmacology*
  • Quinazolines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Thrombin / antagonists & inhibitors*
  • Signal Transduction / drug effects
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • TOR Serine-Threonine Kinases / drug effects*
  • TOR Serine-Threonine Kinases / metabolism
  • Thrombin / metabolism*

Substances

  • Immunosuppressive Agents
  • N3-cyclopropyl-7-((4-(1-methylethyl)phenyl)methyl)-7H-pyrrolo(3, 2-f)quinazoline-1,3-diamine
  • Oligopeptides
  • Pyrroles
  • Quinazolines
  • Receptors, Thrombin
  • palmitoyl-seryl-glycyl-arginyl-arginyl-tyrosyl-glycyl-histidyl-alanyl-leucyl-arginine
  • mTOR protein, rat
  • TOR Serine-Threonine Kinases
  • Thrombin
  • protease-activated receptor 4
  • Sirolimus
  • Platelet Aggregation Inhibitors